Spiriva Respimat (Tiotropium) Gets Asthma Indication in US – Medscape


European Pharmaceutical Review

Spiriva Respimat (Tiotropium) Gets Asthma Indication in US
Medscape
The US Food and Drug Administration (FDA) has approved the long-acting muscarinic antagonist tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for long-term maintenance treatment of asthma in people aged 12 years and older, according to a …
FDA approves Boehringer's asthma treatmentWestfair Online
FDA approves asthma treatment Spiriva RespimatEuropean Pharmaceutical Review

all 3 news articles »

View full post on asthma – Google News

Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis – Medscape

Montelukast: A Review of Recent Studies in Pediatric Asthma and Allergic Rhinitis
Medscape
Montelukast was approved by the Food and Drug Administration (FDA) on February 20, 1998 for the treatment of asthma in children and adults. It has gained widespread acceptance as an adjunct to inhaled corticosteroids and beta-adrenergic agonists in the …

View full post on asthma – Google News